Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
Clinical trial NCT05629806 · UNKNOWN
Trial details
- NCT number
- NCT05629806
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-10
- Primary completion
- 2023-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.